The study focused on combining DNA fragment analysis with two protein biomarkers: cancer antigen 125 (CA-125) - abnormal tissue antigen and epithelial ovarian cancer related protein HE-4.
New study reveals how ovarian cancer shields itself from the immune system, opening doors to innovative immunotherapy methods for more effective treatments. A team of scientists has uncovered a ...